Baseline | Cycle 1 | Cycle 2 | Cycle 3 | Cycle 6 | |
---|---|---|---|---|---|
Sociodemographics (age, migration background, education) | x | ||||
Mean pain intensity on the days with pain (NRS) | x | x | x | x | x |
Worst pain intensity (NRS) | x | x | x | x | x |
Duration of pain (days) | x | x | x | x | x |
Sick leave days | x | x | x | x | x |
Intake of medication against menstrual pain | x | x | x | x | x |
Adverse events and adverse effectsa | x | x | x | x | |
Application of other therapies | x | x | x | x | x |
Body efficacy expectation | x | x | x | x | x |
Credibility of the interventiona | x | ||||
Expectation | x | ||||
Type of menstrual complaintsb | x | x | x | x | x |
Compliancea,b | x | x | x | x |